1. Preto A, Gonçalves J, Rebocho AP, Figueiredo J, Meireles AM, Rocha AS, Vasconcelos HM, Seca H, Seruca R, Soares P, Sobrinho-Simões M

Proliferation and survival molecules implicated in the inhibition of BRAF pathway in thyroid cancer cells harbouring different genetic mutations. BMC cancer 9: 387, 2009. [Article] 

 doi: 10.1186/1471-2407-9-387 PMID: 19878585.

 

2. Preto A, Figueiredo J, Velho S, Ribeiro AS, Soares P, Oliveira C, Seruca R

BRAF provides proliferation and survival signals in MSI colorectal carcinoma cells displaying BRAF(V600E) but not KRAS mutations. The Journal of pathology 214: 320-7, 2008. [Article] 

 doi: 10.1002/path.2295 PMID: 18098337.

 

3. Preto A, Moutinho C, Velho S, Oliveira C, Rebocho AP, Figueiredo J, Soares P, Lopes JM, Seruca R

A subset of colorectal carcinomas express c-KIT protein independently of BRAF and/or KRAS activation. Virchows Archiv : an international journal of pathology 450: 619-26, 2007. [Article] 

 doi: 10.1007/s00428-007-0420-9 PMID: 17487504.

 

4. Preto A, Cameselle-Teijeiro J, Moldes-Boullosa J, Soares P, Cameselle-Teijeiro JF, Silva P, Reis-Filho JS, Reyes-Santías RM, Alfonsín-Barreiro N, Forteza J, Sobrinho-Simões M

Telomerase expression and proliferative activity suggest a stem cell role for thyroid solid cell nests. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 17: 819-26, 2004. [Article] 

 doi: 10.1038/modpathol.3800124 PMID: 15044923.

 

5. Preto A, Singhrao SK, Haughton MF, Kipling D, Wynford-Thomas D, Jones CJ

Telomere erosion triggers growth arrest but not cell death in human cancer cells retaining wild-type p53: implications for antitelomerase therapy. Oncogene 23: 4136-45, 2004. [Article] 

 doi: 10.1038/sj.onc.1207564 PMID: 15064743.

 

6. Preto A, Reis-Filho JS, Ricardo S, Soares P

P63 expression in papillary and anaplastic carcinomas of the thyroid gland: lack of an oncogenetic role in tumorigenesis and progression. Pathology, research and practice 198: 449-54, 2002. [Article] 

 PMID: 12234063.

 

1. Castro L, Alves S, Chaves SR, Costa JL, Soares P, Preto A

RAF-1 promotes survival of thyroid cancer cells harboring RET/PTC1 rearrangement independently of ERK activation. Molecular and cellular endocrinology 415: 64-75, 2015. [Article] 

 doi: 10.1016/j.mce.2015.08.006 PMID: 26265449.